Skip to main content

Nirav Shah, MD, MSHP

Milwaukee, WI
United States

Medical College of Wisconsin

Nirav Shah, MD, MSHP, is currently an Associate Professor of Medicine at the Medical College of Wisconsin, Division of Hematology and Oncology, specializing in lymphoma, stem cell transplant, and CAR-T therapy. He graduated with honors and Alpha Omega Alpha honor society membership from University of Illinois at Chicago College of Medicine in 2008. He then completed his Internal Medicine residency at the Harvard affiliated Massachusetts General Hospital in 2011. Following residency, he went to the University of Pennsylvania where he completed Hematology/Oncology fellowship and received a Master of Science in Health Policy research in 2015. His current focus is the development of dual targeted anti-CD20, anti-CD19 CAR-T cells (CAR20.19) for B-cell malignancies. Results of a Phase 1 trial with CAR20.19 T-cells were published in Nature Medicine in Oct. 2020. Data from that study directed development of three new CAR20.19 clinical trials led by Dr. Shah all actively enrolling patients.

Program Name(s)
Career Development Program
Dr. Shah